Nebivolol recalls

The FDA has published 3 recalls involving Nebivolol since 2014. The latest was reported on 17 Dec 2025. Aurobindo Pharma USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2014

Last 12 months1reported

Class I00% of total

Ongoing2latest 17 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 1 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 1 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why nebivolol is recalled

Companies

Brands

Nebivolol267%
Bystolic133%

By year

2025133%
2024133%
2014133%

Ongoing nebivolol recalls

2 active

Reported	Class	Recall	Company	Reason	Where
17 Dec 2025Drug	CLASS III	Nebivolol Tablets, 20 mg recalled by Glenmark PharmaceuticalsNebivolol	Glenmark Pharmaceuticals Inc., U	Other	Nationwide
25 Dec 2024Drug	CLASS II	Nebivolol Tablets recalled by Aurobindo Pharma USANebivolol	Aurobindo Pharma USA	Nitrosamine Impurity	Nationwide

All nebivolol recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
17 Dec 2025Drug	CLASS III	Nebivolol Tablets, 20 mg recalled by Glenmark PharmaceuticalsNebivolol	Glenmark Pharmaceuticals Inc., U	Other	Nationwide
25 Dec 2024Drug	CLASS II	Nebivolol Tablets recalled by Aurobindo Pharma USANebivolol	Aurobindo Pharma USA	Nitrosamine Impurity	Nationwide
28 May 2014Drug	CLASS II	Bystolic (nebivolol), 20 mg/tablet recalled by Forest PharmaceuticalsBystolic	Forest Pharmaceuticals	Potency & Assay	Nationwide

Should you stop taking Nebivolol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.